MobbleOpen in Mobble ⇢
Business · Corporate earnings · published 2026-09-28 · via Ad-Hoc News

Ceconomy shares gain 2.5% as nine-month EBIT improves

Image via Ad-Hoc News
Image via Ad-Hoc News

Ceconomy stock traded at €4.07 on Xetra on Sept. 28, 2026, up 2.52% from the previous close. For the first nine months of fiscal 2025/26, adjusted EBIT rose by €62 million to €342 million, with revenue at €18.4 billion. The company reaffirmed its full-year adjusted EBIT target of €500 million and said its planned partnership with JD.com is expected to close in the second half of 2026.

Expanded Detail

Ceconomy’s nine-month figures showed adjusted EBIT at €342 million, €62 million higher year on year, on revenue of €18.4 billion. Currency- and portfolio-adjusted sales grew 5%, while the third quarter’s comparable sales rose 8.2%. Online revenue increased 10%, and the adjusted EBIT margin reached 1.86%, up 0.30 percentage points.

The electronics retailer kept its fiscal 2025/26 adjusted EBIT target at €500 million and expects gains across all segments. Its JD.com partnership is slated to close in the second half of 2026, though regulatory clearances remain pending. The shares traded at €4.07, below the 52-week high of €4.59 and above the low of €3.51.

Context

Ceconomy’s improved earnings and JD.com tie-up could affect shoppers, employees, suppliers, and investors in electronics retail. If the partnership closes, customers may see changes in product access, pricing, or delivery options, while staff and suppliers could face shifts in operations. Investors may benefit from stronger profitability, but pending approvals and integration risks may create uncertainty. Broader retail competition could intensify, potentially influencing choices and service quality.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Ad-Hoc News →
Related stories
ATS targets 15% EBIT margin after Q1 revenue miss · Corporate earnings
Live Oak Acquisition Corp. V Short Interest More Than Doubles · Stock markets
Kamada Sets 2026 Revenue Outlook on Plasma Therapy Demand · Corporate earnings
TG Therapeutics Gets Hold Consensus From Analysts · Stock markets
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Die Ceconomy-Aktie steigt am 28.09.2026 um 2,52 Prozent.” Browse more stories.